Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Cholangiocarcinoma × Chemoradiotherapy × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Squamous Cell 3 Uterine Cervical Neoplasms 2 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Tonsillar Neoplasms 1 Resectable Esophageal Cancer 1 Pharyngeal Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Muscle Invasive Bladder Cancer 1 Melanoma 1 Limited Stage Small Cell Lung Cancer 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Adenosquamous 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 25 Cisplatin 17 pembrolizumab 6 Capecitabine 5 Fluorouracil 4 durvalumab 3 Taxes 3 Oxaliplatin 3 Carboplatin 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2 trametinib 2 pemigatinib 2 ivosidenib 2 infigratinib 2 derazantinib 2 atezolizumab 2 Radiotherapy 2 Radiosurgery 2 Platinum 2 Nivolumab 2 Liver Transplantation 2 Leucovorin 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tucatinib 1 trifluridine tipiracil drug combination 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡